{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:40:26Z","timestamp":1782603626068,"version":"3.54.5"},"reference-count":72,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T00:00:00Z","timestamp":1607472000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) gained worldwide attention at the end of 2019 when it was identified to cause severe respiratory distress syndrome. While it primarily affects the respiratory system, we now have evidence that it affects multiple organ systems in the human body. Cardiac manifestations may include myocarditis, life threatening arrhythmias, acute coronary syndrome, systolic heart failure, and cardiogenic shock. Myocarditis is increasingly recognized as a complication of Coronavirus-19 (COVID-19) and may result from direct viral injury or from exaggerated host immune response. The diagnosis is established similar to other etiologies, and is based on detailed history, clinical exam, laboratory findings and non-invasive imaging studies. When available, cardiac MRI is the preferred imaging modality. Endomyocardial biopsy may be performed if the diagnosis remains uncertain. Current management is mainly supportive with the potential addition of interventions recommended for severe COVID-19 disease, such as remdesivir, steroids, and convalescent plasma. In the setting of cardiogenic shock and refractory, life-threatening arrhythmias that persist despite medical therapy, advanced mechanical circulatory support devices should be considered. Ultimately, early recognition and aggressive intervention are key factors in reducing morbidity and mortality. Our management strategy is expected to evolve further as we learn more about COVID-19 disease and the associated cardiac complications.<\/jats:p>","DOI":"10.3390\/medicina56120678","type":"journal-article","created":{"date-parts":[[2020,12,9]],"date-time":"2020-12-09T09:17:58Z","timestamp":1607505478000},"page":"678","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Update on COVID-19 Myocarditis"],"prefix":"10.3390","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2948-039X","authenticated-orcid":false,"given":"Arianne Clare C.","family":"Agdamag","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan B.","family":"Edmiston","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Charpentier","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Chowdhury","sequence":"additional","affiliation":[{"name":"Cardiology, North Central Heart, Sioux Falls, SD 57108, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Fraser","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valmiki R.","family":"Maharaj","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary S.","family":"Francis","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8381-6299","authenticated-orcid":false,"given":"Tamas","family":"Alexy","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,12,9]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2020, October 22). Naming the Coronavirus Disease (COVID-19) and the Virus that Causes It. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/technical-guidance\/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causes-it."},{"key":"ref_2","unstructured":"World Health Organization (2020, October 22). WHO Director-General\u2019s Opening Remarks at the Media Briefing on COVID-19\u201311 March 2020. Available online: https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of Cardiac Injury with Mortality in Hospitalized Patients With COVID-19 in Wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1631\/jzus.B2000083","article-title":"An overview of COVID-19","volume":"21","author":"Shi","year":"2020","journal-title":"J. Zhejiang Univ. Sci. B"},{"key":"ref_5","unstructured":"World Health Organization (2020, October 22). SARS (Severe Acute Respiratory Syndrome). Available online: https:\/\/www.who.int\/ith\/diseases\/sars\/en."},{"key":"ref_6","unstructured":"World Health Organization (2020, October 22). Middle East Respiratory Syndrome (MERS), Available online: https:\/\/www.cdc.gov\/coronavirus\/mers\/index.html."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0140-6736(20)30154-9","article-title":"A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster","volume":"395","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1038\/s41401-020-0485-4","article-title":"Structural and functional properties of SARS-CoV-2 spike protein: Potential antivirus drug development for COVID-19","volume":"41","author":"Huang","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12575-020-00128-2","article-title":"A comprehensive review of COVID-19 characteristics","volume":"22","author":"Esakandari","year":"2020","journal-title":"Biol. Proced. Online"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ijso.2020.08.017","article-title":"The transmission modes and sources of COVID-19, A systematic review","volume":"26","author":"Rahman","year":"2020","journal-title":"Int. J. Surg. Open"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s13578-020-00404-4","article-title":"SARS-CoV-2 and COVID-19, The most important research questions","volume":"10","author":"Yuen","year":"2020","journal-title":"Cell Biosci."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"102474","DOI":"10.1016\/j.amjoto.2020.102474","article-title":"Upper airway symptoms in coronavirus disease 2019 (COVID-19)","volume":"41","author":"Lovato","year":"2020","journal-title":"Am. J. Otolaryngol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"362","DOI":"10.7326\/M20-3012","article-title":"Prevalence of Asymptomatic SARS-CoV-2 Infection: A Narrative Review","volume":"173","author":"Oran","year":"2020","journal-title":"Ann. Internet Med."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Paranjpe, I., Russak, A., De Freitas, J.K., Lala, A., Miotto, R., Vaid, A., Johnson, K.W., Danieletto, M., Golden, E., and Meyer, D. (2020). Clinical Characteristics of Hospitalized Covid-19 Patients in New York City. medRxiv.","DOI":"10.1101\/2020.04.19.20062117"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e000406","DOI":"10.1136\/fmch-2020-000406","article-title":"Clinicopathological characteristics of 8697 patients with COVID-19 in China: A meta-analysis","volume":"8","author":"Zhu","year":"2020","journal-title":"Fam. Med. Commun. Health"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1148\/radiol.2020200274","article-title":"Emerging 2019 Novel Coronavirus (2019-nCoV) Pneumonia","volume":"295","author":"Song","year":"2020","journal-title":"Radiology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","article-title":"Pathological findings of COVID-19 associated with acute respiratory distress syndrome","volume":"8","author":"Xu","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian","year":"2020","journal-title":"Mod. Pathol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1093\/eurheartj\/ehaa231","article-title":"Coronaviruses and the cardiovascular system: Acute and long-term implications","volume":"41","author":"Xiong","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1136\/heartjnl-2020-317056","article-title":"Cardiovascular manifestations and treatment considerations in COVID-19","volume":"106","author":"Kang","year":"2020","journal-title":"Heart"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1161\/01.CIR.93.5.841","article-title":"Report of the 1995 World Health Organization\/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies","volume":"93","author":"Richardson","year":"1996","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur. Heart J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1161\/CIR.0000000000000745","article-title":"Recognition and Initial Management of Fulminant Myocarditis: A Scientific Statement from the American Heart Association","volume":"141","author":"Kociol","year":"2020","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1253\/circj.CJ-10-0452","article-title":"Clinical Research Committee on Myocarditis Associated with Influenza APiJobJCS. A national survey on myocarditis associated with the 2009 influenza A (H1N1) pandemic in Japan","volume":"74","author":"Ukimura","year":"2010","journal-title":"Circ. J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.5144\/0256-4947.2016.78","article-title":"Acute myocarditis associated with novel Middle east respiratory syndrome coronavirus","volume":"36","author":"Alhogbani","year":"2016","journal-title":"Ann. Saudi Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev.pathmechdis.3.121806.151534","article-title":"Molecular biology and pathogenesis of viral myocarditis","volume":"3","author":"Esfandiarei","year":"2008","journal-title":"Ann. Rev. Pathol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.4049\/jimmunol.113.6.1726","article-title":"Involvement of T lymphocytes in the pathogenesis of coxsackie virus B3 heart disease","volume":"113","author":"Woodruff","year":"1974","journal-title":"J. Immunol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.RES.85.6.551","article-title":"Susceptibility to myocarditis is dependent on the response of alphabeta T lymphocytes to coxsackieviral infection","volume":"85","author":"Opavsky","year":"1999","journal-title":"Circ. Res."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1056\/NEJM198910193211601","article-title":"A prospective, randomized, controlled trial of prednisone for dilated cardiomyopathy","volume":"321","author":"Parrillo","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM199508033330501","article-title":"A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators","volume":"333","author":"Mason","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1136\/adc.2003.034686","article-title":"Immunosuppressive therapy in acute myocarditis: An 18 year systematic review","volume":"89","author":"Hia","year":"2004","journal-title":"Arch. Dis. Child."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.CIR.100.10.1102","article-title":"Treatment of experimental viral myocarditis with interleukin-10","volume":"100","author":"Nishio","year":"1999","journal-title":"Circulation"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1161\/01.CIR.0000072766.67150.51","article-title":"Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction","volume":"107","author":"Kuhl","year":"2003","journal-title":"Circulation"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1006\/clin.1997.4342","article-title":"Autoimmunity in myocarditis: Relevance of animal models","volume":"83","author":"Huber","year":"1997","journal-title":"Clin. Immunol. Immunopathol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.4049\/jimmunol.154.6.2983","article-title":"Molecular mimicry, anti-coxsackievirus B3 neutralizing monoclonal antibodies, and myocarditis","volume":"154","author":"Gauntt","year":"1995","journal-title":"J. Immunol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.pcad.2009.11.006","article-title":"Myocarditis","volume":"52","author":"Blauwet","year":"2010","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0140-6736(80)92989-X","article-title":"Carditis associated with coronavirus infection","volume":"2","author":"Riski","year":"1980","journal-title":"Lancet"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Nakagawa, K., Narayanan, K., Wada, M., and Makino, S. (2018). Inhibition of Stress Granule Formation by Middle East Respiratory Syndrome Coronavirus 4a Accessory Protein Facilitates Viral Translation, Leading to Efficient Virus Replication. J. Virol., 92.","DOI":"10.1128\/JVI.00902-18"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1128\/JVI.02472-07","article-title":"Severe acute respiratory syndrome coronavirus nsp1 suppresses host gene expression, including that of type I interferon, in infected cells","volume":"82","author":"Narayanan","year":"2008","journal-title":"J. Virol."},{"key":"ref_41","first-page":"1281","article-title":"Association of Cardiac Infection With SARS-CoV-2 in Confirmed COVID-19 Autopsy Cases","volume":"5","author":"Lindner","year":"2020","journal-title":"J. AMA Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.cjco.2020.05.005","article-title":"COVID-19 and Myocarditis: What Do We Know So Far?","volume":"2","author":"Pirzada","year":"2020","journal-title":"CJC Open"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.cpcardiol.2012.07.003","article-title":"Sex and gender differences in myocarditis and dilated cardiomyopathy","volume":"38","author":"Fairweather","year":"2013","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/eurjhf\/hfq229","article-title":"Prognostic electrocardiographic parameters in patients with suspected myocarditis","volume":"13","author":"Ukena","year":"2011","journal-title":"Eur. J. Heart Fail."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ejim.2020.06.015","article-title":"Electrocardiographic features of patients with COVID-19 pneumonia","volume":"78","author":"Angeli","year":"2020","journal-title":"Eur. J. Internet Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"966.e1","DOI":"10.1016\/j.cjca.2020.03.028","article-title":"Characteristic Electrocardiographic Manifestations in Patients With COVID-19","volume":"36","author":"He","year":"2020","journal-title":"Can. J. Cardiol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular Magnetic Resonance in Nonischemic Myocardial Inflammation: Expert Recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"e010897","DOI":"10.1161\/CIRCIMAGING.120.010897","article-title":"Diffuse Myocardial Inflammation in COVID-19 Associated Myocarditis Detected by Multiparametric Cardiac Magnetic Resonance Imaging","volume":"13","author":"Luetkens","year":"2020","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"ref_50","first-page":"3","article-title":"Myocarditis. A histopathologic definition and classification","volume":"1","author":"Aretz","year":"1987","journal-title":"Am. J. Cardiovasc. Pathol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/0735-1097(89)90465-8","article-title":"Insensitivity of right ventricular endomyocardial biopsy in the diagnosis of myocarditis","volume":"14","author":"Chow","year":"1989","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0025-6196(12)61286-5","article-title":"Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis: Implications for role of sampling error","volume":"64","author":"Hauck","year":"1989","journal-title":"Mayo Clin. Proc."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1093\/eurheartj\/ehn296","article-title":"Acute viral myocarditis","volume":"29","author":"Dennert","year":"2008","journal-title":"Eur. Heart J."},{"key":"ref_54","unstructured":"Cardiology, E.S.O. (2020, October 22). ESC Guidance for the Diagnosis and Management of CV Disease during the COVID-19 Pandemic. Available online: https:\/\/www.escardio.org\/Education\/COVID-19-and-Cardiology\/ESC-COVID-19-Guidance."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Escher, F., Pietsch, H., Aleshcheva, G., Bock, T., Baumeier, C., Elsaesser, A., Wenzel, P., Hamm, C., Westenfeld, R., and Schiltheiss, M. (2020). Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail.","DOI":"10.1002\/ehf2.12805"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","article-title":"SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome","volume":"4","author":"Dolhnikoff","year":"2020","journal-title":"Lancet Child. Adolesc. Health"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"107300","DOI":"10.1016\/j.carpath.2020.107300","article-title":"Myocarditis is rare in COVID-19 autopsies: Cardiovascular findings acrros 277 postmortem examinations","volume":"50","author":"Halushka","year":"2020","journal-title":"Cardiovasc. Pathol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the Treatment of Covid-19-Final Report","volume":"10","author":"Beigel","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0140-6736(20)31042-4","article-title":"Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19, an open-label, randomised, phase 2 trial","volume":"395","author":"Hung","year":"2020","journal-title":"Lancet"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Rajendran, K., Krishnasamy, N., Rangarajan, J., Rathinam, J., Natarajan, M., and Ramachandran, A. (2020). Convalescent plasma transfusion for the treatment of COVID-19, Systematic review. J. Med. Virol.","DOI":"10.1002\/jmv.25961"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"m2648","DOI":"10.1136\/bmj.m2648","article-title":"Dexamethasone in the management of covid-19","volume":"370","author":"Johnson","year":"2020","journal-title":"BMJ"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJMoa2022926","article-title":"Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19","volume":"383","author":"Group","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2, should inhibitors of the renin-angiotensin system be withdrawn in patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_64","first-page":"e102","article-title":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","volume":"382","author":"Reynolds","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1001\/jamacardio.2020.1096","article-title":"Cardiac Involvement in a Patient with Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Inciardi","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1001\/jamacardio.2020.1834","article-title":"Risk of QT Interval Prolongation Associated with Use of Hydroxychloroquine with or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Mercuro","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.healun.2020.04.019","article-title":"Ethical considerations regarding heart and lung transplantation and mechanical circulatory support during the COVID-19 pandemic: An ISHLT COVID-19 Task Force statement","volume":"39","author":"Holm","year":"2020","journal-title":"J. Heart Lung. Transpl."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.cjco.2020.04.003","article-title":"Cardiovascular Collapse in COVID-19 Infection: The Role of Venoarterial Extracorporeal Membrane Oxygenation (VA-ECMO)","volume":"2","author":"Chow","year":"2020","journal-title":"CJC Open"},{"key":"ref_71","unstructured":"Document, E.G. (2020, October 22). ELSO Guidance Document: ECMO for COVID-19 Patients with Severe Cardiopulmonary Failure. Available online: https:\/\/www.elso.org\/Portals\/0\/Files\/pdf\/ECMO%20for%20COVID%2019%20Guidance%20Document.Final%2003.24.2020.pdf."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of Fatal Outcomes of Patients with Coronavirus Disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol."}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/12\/678\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:42:53Z","timestamp":1760179373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/56\/12\/678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,9]]},"references-count":72,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["medicina56120678"],"URL":"https:\/\/doi.org\/10.3390\/medicina56120678","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,9]]}}}